0001861657 EX-FILING FEES 0001861657 2025-10-17 2025-10-17 0001861657 1 2025-10-17 2025-10-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

FORM S-3

(Form Type)

 

THARIMMUNE, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

   Security Type 

Security Class

Title

  Fee Calculation Rule 

Amount

Registered (2)

 

Proposed Maximum

Offering Price Per

Share

 

Maximum

Aggregate

Offering Price

   Fee Rate 

Amount of

Registration Fee

 
Fees to Be Paid  Equity  Common Stock, par value $0.0001 per share  Other (1)  326,750 (3)  $2.89  $944,308   $0.00013810   $131 
Fees Previously Paid                               
Total Offering Amounts  $944,308        $131 
Total Fees Previously Paid             - 
Total Fee Offsets             - 
Net Fee Due            $131 

 

(1) Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended (the “Securities Act”), based upon the average of the high and low prices for a share of the registrant’s common stock as reported on The Nasdaq Capital Market on October 13, 2025.

 

(2) Pursuant to Rule 416 under the Securities Act, the shares of common stock offered hereby also include an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions.

 

(3) Represents the resale of (i) 39,573 shares of our common stock issuable upon exercise of the warrants issued in connection with a private placement in June 2024, (ii) 57,687 shares of our common stock issuable upon exercise of the warrants issued in connection with a private placement in December 2024, (iii) 118,243 shares of our common stock issuable upon exercise of the Series A warrants issued in connection with the private placement in June 2025, (iv) 59,119 shares of our common stock issuable upon exercise of the Series B warrants issued in connection with a private placement in June 2025 and (v) 52,128 shares of our common stock issuable upon exercise of the warrants.

 N/A